tirzepatide surmount-1 weight loss percent 72 weeks SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, Tirzepatide (ZEPBOUND) Approved for Chronic
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17

























